This study was aimed at assessing the impact of a non-medical recommendation on drug-utilisation patterns and clinical outcomes in a central Region of Italy (Tuscany).
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons
Tuccori, Marco
2021-01-01
Abstract
This study was aimed at assessing the impact of a non-medical recommendation on drug-utilisation patterns and clinical outcomes in a central Region of Italy (Tuscany).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2021 - 2° Convertino (Infliximab pre-post) - Clin Exp Rheumatol.pdf
non disponibili
Licenza:
Accesso ristretto
Dimensione
3.02 MB
Formato
Adobe PDF
|
3.02 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
